Please Wait
Applying Filters...
Menu
Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fiercebiotech.com/biotech/acrivon-therapeutics-secures-100m-to-give-eli-lilly-cancer-drug-another-try-fund-2-solid

K. LaHucik FIERCEBIOTECH
12 Nov 2021
Boosting I-O by targeting a cellular stress pathway
Boosting I-O by targeting a cellular stress pathway

27 Oct 2021

// Angus Liu FIERCEBIOTECH

https://www.fiercebiotech.com/research/genetic-signature-behind-drugs-astrazeneca-bayer-eli-lilly-boost-cancer-immunotherapy

Angus Liu FIERCEBIOTECH
27 Oct 2021
Analysts to Lilly: Why did Trulicity and Taltz come up short?
Analysts to Lilly: Why did Trulicity and Taltz come up short?

01 May 2019

// Eric Sagonowsky FIERCE PHARMA

https://www.fiercepharma.com/pharma/lilly-s-light-sales-for-trulicity-taltz-prompt-analyst-questions

Eric Sagonowsky FIERCE PHARMA
01 May 2019

https://endpts.com/suffering-a-series-of-setbacks-eli-lillys-oncology-group-quietly-executes-2-of-its-top-mid-stage-drugs/

John Carroll ENDPTS
30 Apr 2019
Lilly dumps phase 2 cancer drugs that survived previous cull
Lilly dumps phase 2 cancer drugs that survived previous cull

30 Apr 2019

// Amirah Al Idrus FIERCE BIOTECH

https://www.fiercebiotech.com/biotech/lilly-dumps-phase-2-cancer-drugs-survived-previous-cull

Amirah Al Idrus FIERCE BIOTECH
30 Apr 2019